ZIAGEN- abacavir sulfate solution 
GlaxoSmithKline Inc

----------

PRINCIPAL DISPLAY PANEL

NDC 49702-222-48

ZIAGEN®

(abacavir)

ORAL SOLUTION

20 mg/mL

Each mL contains abacavir sulfate equivalent to 20 mg of abacavir.

Rx only

Notice to Authorized Dispenser:

Each time ZIAGEN is dispensed, give the patient a Medication Guide and Warning Card from the carton.

240 mL

 
10000000014384 Rev. 4/17
Ziagen Oral Solution 240 mL Carton
ZIAGEN 
abacavir sulfate solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:53873-034
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ABACAVIR SULFATE (UNII: J220T4J9Q2) (ABACAVIR - UNII:WR2TIP26VS) ABACAVIR20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
SORBITOL (UNII: 506T60A25R)  
WATER (UNII: 059QF0KO0R)  
Product Characteristics
ColorYELLOW (Yellowish) Score    
ShapeSize
FlavorSTRAWBERRY (Strawberry-banana) Imprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53873-034-00240 mL in 1 BOTTLE; Type 0: Not a Combination Product01/28/1999
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02097801/28/1999
Labeler - GlaxoSmithKline Inc (205556368)

Revised: 12/2017
Document Id: f6e329f4-50c3-4294-8b03-61d26f9da63a
Set id: 9f4ce2d3-ce4d-4be3-b727-fb61cdf1e179
Version: 2
Effective Time: 20171211
 
GlaxoSmithKline Inc